Trial intelligence / Profile preview

OPC-41061 for Cardiac Edema in Congestive Heart Failure

jRCT2080220391Phase 3

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
May 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in heart failure (HF) and edema secondary to heart failure comparing OPC-41061 arm with Placebo arm (2 arms).

02

Drugs

tolvaptan
03

Conditions

heart failure (HF)edema secondary to heart failure

Beyond the preview

Go deeper on jRCT2080220391.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220391.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call